A novel treatment for heart failure targets myocardial fibrosis

Cleland, J. G.F. , Pellicori, P. and González, A. (2021) A novel treatment for heart failure targets myocardial fibrosis. Nature Medicine, 27(8), pp. 1343-1344. (doi: 10.1038/s41591-021-01457-9) (PMID:34385705)

Full text not currently available from Enlighten.


A new trial suggests that pirfenidone, an approved treatment for idiopathic pulmonary fibrosis, may also reduce myocardial fibrosis in patients with heart failure who have a preserved left ventricular ejection fraction.

Item Type:Articles
Glasgow Author(s) Enlighten ID:Cleland, Professor John and Pellicori, Dr Pierpaolo
Authors: Cleland, J. G.F., Pellicori, P., and González, A.
College/School:College of Medical Veterinary and Life Sciences > Institute of Health and Wellbeing > Robertson Centre
Journal Name:Nature Medicine
Publisher:Nature Research
ISSN (Online):1546-170X
Published Online:12 August 2021

University Staff: Request a correction | Enlighten Editors: Update this record